Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1729829 LONDON, X0
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,618,381
-$4,949,009 QoQ
Shares Held
431,447
-30.6% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 280 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. COLL ranks #9 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,279,333 $163,792,869
2 UTHR
UNITED THERAPEUTICS Corp
 233,639 $126,592,619
3 VTRS
Viatris Inc
 6,180,223 $98,141,941
4 SUPN
Supernus Pharmaceuticals, Inc.
 922,166 $42,889,940
5 TAK
Takeda Pharmaceutical Co Ltd
 2,207,432 $35,385,134
6 XERS
Xeris Biopharma Holdings, Inc.
 2,893,749 $22,918,492
7 KNSA
Kiniksa Pharmaceuticals International, plc
 304,080 $19,445,916
8 ANIP
Ani Pharmaceuticals Inc
 192,945 $15,971,987

All Filings in COLL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,618,381 431,447
2026-03-31 $20,567,390 621,935
2025-12-31 $12,419,604 268,242
2025-09-30 $11,216,359 320,559
2025-06-30 $2,805,601 94,880
2025-03-31 $1,598,915 53,565
2024-12-31 $6,240,342 217,813
2024-09-30 $2,633,200 68,147
2024-06-30 $1,753,482 54,456
2023-12-31 $492,510 16,001
2023-09-30 $2,838,673 127,010
2023-06-30 $335,587 15,616
2023-03-31 $838,786 34,964
2022-03-31 $401,071 19,699
2021-12-31 $1,529,443 81,876
2021-09-30 $519,063 26,295
2021-06-30 $425,874 18,015
2021-03-31 $470,658 19,859
2020-12-31 $499,848 24,955